Research Spotlight: Epinephrine Use in the Treatment of Anaphylaxis in Infants and Toddlers
The odds of being treated with epinephrine were five times greater when an anaphylaxis action plan was provided.
Browse Allergy & Immunology News
Get the latest articles and press releases from the Allergy & Clinical Immunology
Unit at Mass General Hospital.
23 results
Researcher Discover Why Only Some People Experience Long-Term Benefits from Peanut Allergy Treatments
The findings may help investigators improve allergy treatments so that all patients can benefit.
Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis after SARS-CoV-2 mRNA-1273 (“Moderna”) Vaccine: A Case Report.
Clinicians describe the presentation and successful treatment of delayed localized necrotizing inflammatory myositis following the third dose of the mRNA-1273 SARS-CoV-2 vaccine.
Research Spotlight: Lower Hydroxychloroquine Dosing is Less Effective in Preventing Lupus Flares
When patients with lupus received lower dosing of hydroxychloroquine—in accordance with current ophthalmology guidelines—they had a higher risk of lupus flares than when they were taking a higher dose of the medication.
New Insights into the Mechanisms Behind Crohn's Disease Point to Potential Therapeutic Target
Researchers have found that inhibitors of enzymes called topoisomerases can reverse intestinal abnormalities in mice with inflammation characteristic of Chron's disease.
New details behind the body’s response to tuberculosis could lead to a more effective vaccine
New details behind the body’s response to tuberculosis could lead to a more effective vaccine. New details behind the body’s response to tuberculosis could lead to a more effective vaccine. Key Takeaways • In a person with active tuberculosis,
Study identifies specific drugs that can prevent disease-causing activity of key immune cells
Study identifies specific drugs that can prevent disease-causing activity of key immune cells. Study identifies specific drugs that can prevent disease-causing activity of key immune cells. Key Takeaways • Macrophages are polarized, or activated,
Study supports safety of COVID-19 vaccines in people with a history of severe allergic reactions
Study supports safety of COVID-19 vaccines in people with a history of severe allergic reactions. Study supports safety of COVID-19 vaccines in people with a history of severe allergic reactions. Key Takeaways • Among Mass General Brigham
Scientists discover how immune cells survive their battle with cancer
Scientists discover how immune cells survive their battle with cancer. Scientists discover how immune cells survive their battle with cancer. Key Takeaways • Cytotoxic T lymphocytes, which recognize and destroy cancer cells, must receive critical
Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose
Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose. Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose. Key Takeaways • Among individuals who had an allergic reaction to
Showing 1 - 10 of 23 results